Clinical trials
Cholangiocarcinoma trials in the United States with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weill Medical College of Cornell University | 4 |
| NGM Biopharmaceuticals, Inc | 2 |
| Beijing InnoCare Pharma Tech Co., Ltd. | 1 |
| Benaroya Research Institute | 1 |
| Central Texas Veterans Health Care System | 1 |
| Delcath Systems Inc. | 1 |
| Innovative Digestive Health Education and Research Inc | 1 |
| SpeciCare | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 12 |
| Bile Duct Neoplasms | 7 |
| Pancreatic Neoplasms | 6 |
| Colorectal Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Renal Cell | 3 |
| Melanoma | 3 |
| Stomach Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.